Hepatoprotective and nephroprotective activities of Juniperus sabina L. aerial parts
Journal Title: Journal of Pharmacy & Pharmacognosy Research - Year 2017, Vol 5, Issue 1
Abstract
Context: Previous studies indicated that Juniperus species exhibited promising hepatoprotective activity. Aims: To evaluate the hepatoprotective and nephroprotective activity of the total alcohol extract of the aerial parts of Juniperus sabina against carbon tetrachloride (CCl4) induced toxicity using male Wistar rats as experimental animals. Methods: Daily oral administration of two doses (200 and 400 mg/kg) of the total extract of the aerial parts of J. sabina for seven days followed by one dose of CCl4 (1.25 mL/kg) at day 6. Liver and kidney functions were monitored via measuring serum and tissue parameters as well as histopathological study. Normal rats, rats treated only with CCl4 and rats treated with CCl4 and silymarin were used as controls. Results: The higher dose showed 47, 50, 38, 17 and 42% decrease in the levels of AST, ALT, GGT, ALP, and bilirubin respectively. Animals received the total extract of J. sabina showed a significant dose-dependent recovery of the NP-SH contents, total proteins, and reduction the level of MDA in both liver and kidney tissues. Histopathological study revealed improvement in the architecture of hepatocytes and kidney cells. Conclusions: The hepatoprotective effect offered by J. sabina crude extract at the two used doses was found to be significant in all serum parameters. Histopathological study revealed moderate improvement in the architecture of the liver cells that add another indication of protection. Improvement of kidney function was less than liver function.
Nanocarriers for skin delivery of cosmetic antioxidants
The demand of natural skin care products is steadily growing since consumers perceive them as safe. Currently, cosmetic manufacturers are focusing their efforts on developing innovative natural products to address skin-a...
Neuroprotective effects of Thalassia testudinum leaf extract BM-21 on focal ischemia in rats
Context: The extract from the marine plant Thalassia testudinum BM-21, standardized to thalassiolin B content (5.8 ± 0.3%), possesses antioxidant, anti-inflammatory and neuroprotective effects on acrylamide-induced neuro...
Clinical evaluation of patients with benign prostatic hyperplasia, treated with the natural product Calprost®: a randomized, controlled study
Context: Benign Prostatic Hyperplasia (BPH) is a common disease that course with Lower Urinary Tract Symptoms (LUTS), mainly in over 50 years-old men. Commonly indicated drugs such as alpha adrenergic-blockers are life-t...
Possible hepatotoxic consequence of nevirapine use in juvenile albino rats
Context: Nevirapine (NVP) is used in human immunodeficiency virus exposed neonates. This could present safety concern due to decreased liver metabolizing enzymes activity and renal clearance in neonates. Aims: To determ...
Therapeutic potential of the novel hybrid molecule JM-20 against focal cortical ischemia in rats
Context: Despite the great mortality and morbidity of stroke, treatment options remain limited. We previously showed that JM-20, a novel synthetic molecule, possessed a strong neuroprotective effect in rats subjected to...